Contact

News archive

2015

Archives
Categories
8 December 2015
| ,
Mithra Acquires 100% Rights of Myring and Zoreline® and Closes first Distribution Deal
Press release
3 December 2015
|
Mithra Pharmaceuticals Reacts to Unfounded Declarations in the Press
Press release
18 November 2015
| ,
Mithra Pharmaceuticals SA/NV Announces the Last Patient Enrollment in the Pharmacodynamics & Pharmacokinetics Studies of the Zoreline® Implant 10.8 mg
Press release
17 November 2015
|
Mithra Pharmaceuticals Invests EUR 75.2 Million in Flemalle
Press release
21 October 2015
|
Mithra Pharmaceuticals Selects Chiltern as CRO for the Phase II Clinical Trials of its Product Candidate Donesta®
Press release
1 October 2015
|
Mithra Pharmaceuticals Announces Strengthening of its Management Team
Press release
30 September 2015
New Market Share Record for Mithra Pharmaceuticals in August 2015
Press release
4 September 2015
| ,
Mithra Pharmaceuticals Announces its First Half 2015 Financial Results and Operational Progress
Press release
26 August 2015
|
The European Journal of Contraception and Reproductive Health Care Publishes Two Scienfitic Articles About E4 (Estetrol) Dinox Phase II Study: Two Of The Most Read Papers By The Scientific Community
Press release
14 August 2015
|
Mithra Pharmaceuticals Sa/Nv Receives Authorisation to Carry Out its Food Effect Study Mit-Es0001-C101
7 August 2015
| ,
Exercise Overallotment Warrant Denominator
30 July 2015
| ,
Exercise of the Over-allotment Option and End of the Stabilisation Period in Relation to the Initial Public Offering
17 July 2015
Mithra Pharmaceuticals SA/NV Announces That it Grew to Record Market Share in Contraception in Belgium
Press release
17 July 2015
|
Mithra Pharmaceuticals SA/NV Announces a Positive Evolution of the On-going Pharmacodynamics Studies for its Three-month Implant Zoreline®
Press release
16 July 2015
|
Mithra Pharmaceuticals SA/NV Signs Contract Extension with Pharmaceutica SARL
Press release
16 July 2015
|
Mithra Pharmaceuticals SA/NV Selects PRA Health Sciences as CRO for Phase III Clinical Trial
Press release
11 July 2015
| ,
Transparency Notifications
Press release
1 July 2015
| ,
Information on the total number of voting rights and shares
29 June 2015
|
Mithra raises EUR 72.3 million in succesfull initial public offering
26 June 2015
|
Mithra Announces Narrowing Of The Price Range Of Its Initial Public Offering
23 June 2015
|
Mithra Announces Coverage Of Base Offering Throughout Price Range
18 June 2015
|
Mithra launches its Initial Public Offering on Euronext Brussels
8 June 2015
|
Mithra announces intention to launch an Initial Public Offering on Euronext Brussels
Load more
Contact